Charles River Laboratories International, Inc. (CRL)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 221.81 |
| Open | 224.27 |
| Bid | 202.00 x 900 |
| Ask | 245.00 x 1100 |
| Day's Range | 225.63 - 233.91 |
| 52 Week Range | 161.65 - 275.00 |
| Volume | |
| Avg. Volume | 510,724 |
| Market Cap | 12.026B |
| Beta (5Y Monthly) | 1.38 |
| PE Ratio (TTM) | 27.40 |
| EPS (TTM) | 8.52 |
| Earnings Date | Aug 07, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 254.80 |
ZacksHere's How Charles River (CRL) is Placed Ahead of Q2 Earnings
Growth across Microbial Solutions and Biologics Testing and CDMO businesses is likely to have contributed to Charles River's (CRL) Q2 revenues, offset by lower biopharmaceutical demand.
Business WireCharles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery
WILMINGTON, Mass. & SAN FRANCISCO, July 24, 2024--Charles River and Autobahn Labs announce collaborative program; Charles River CSO Justin Bryans joins Autobahn's Board of Directors
Business WireCharles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call
WILMINGTON, Mass., July 16, 2024--Charles River Laboratories schedules second-quarter 2024 earnings release and conference call for Wednesday, August 7th.
© 2024 Yahoo. All rights reserved.